ConductScience.org, home

Trial · NCT07889895

AI Prediction of PIVC-Related Phlebitis

NCT07889895, Completed, Kutahya Health Sciences University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. AI Prediction of PIVC-Related Phlebitis. Trials, record NCT07889895. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07889895

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
AI Prediction of PIVC-Related Phlebitis
NCT number
NCT07889895
Status
Completed
Enrollment
461 participants, actual
Lead sponsor
Kutahya Health Sciences University
Conditions
Artificial Intelligence, Phlebitis After Infusion, Phlebitis
Interventions
Artificial Intelligence-Based Phlebitis Detection Model
First posted
2026-10-22
Last updated
2026-10-22

Source ClinicalTrials.gov

Registered outcomes2

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryPeripheral Intravenous Catheter-Related Phlebitis OccurrenceFrom peripheral intravenous catheter insertion until catheter removal or up to 7 days after insertion, whichever occurs first
Occurrence of peripheral intravenous catheter-related phlebitis, assessed using the Visual Infusion Phlebitis Scale. The Visual Infusion Phlebitis Scale scores range from 0 to 5 (0 = healthy intravenous site, no signs of phlebitis; 5 = advanced stage thrombophlebitis). Higher scores indicate a worse outcome. Phlebitis will be defined as a Visual Infusion Phlebitis Scale score of 2 or higher.
PrimaryPerformance of the AI-Based Prediction ModelUp to 14 months
Photographs of peripheral intravenous catheter-related phlebitis sites will be captured in real time using a mobile phone from patients diagnosed with phlebitis. After the required number of images has been collected from all patients, the images will be graded by expert nurses and a physician using the Visual Infusion Phlebitis Scale (range 0 to 5; 0 = healthy intravenous site, 5 = advanced stage thrombophlebitis; higher scores indicate a worse outcome). The labeled dataset will then be divided into training, validation, and test sets. A deep learning model will be developed using the training and validation sets, and the final performance of the model will be determined on the test set using sensitivity, specificity, accuracy, precision, recall, and F1-score (each ranging from 0 to 1; higher values indicate better performance), and calibration.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07889895

GET https://conductscience.org/api/trials/v1/NCT07889895/registered